Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. Shares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the S&P 500 has soared by more than 5%. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting